Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas P Restifo

Showing results (191-200 of 260) with videos related to

Pageof 26
Sort By:
Immunity|April 23, 2013
MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancerJan C Dudda, Bruno Salaun, Yun Ji, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 19, 2019
Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With GlioblastomaStephanie L Goff, Richard A Morgan, James C Yang, et al.
Cancer Research|July 5, 2002
Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsivenessEna Wang, Lance D Miller, Galen A Ohnmacht, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 25, 2007
T-cell receptor gene therapy of established tumors in a murine melanoma modelJohn D Abad, Claudia Wrzensinski, Willem Overwijk, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunityChristian S Hinrichs, Zachary A Borman, Lydie Cassard, et al.
BMC Cancer|October 21, 2011
Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68Maria Libera Ascierto, Andrea Worschech, Zhiya Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2011
Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapySteven A Rosenberg, James C Yang, Richard M Sherry, et al.
Nature Reviews. Immunology|October 2, 2019
Defining 'T cell exhaustion'Christian U Blank, W Nicholas Haining, Werner Held, et al.
Blood|October 26, 2010
Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapyChristian S Hinrichs, Zachary A Borman, Luca Gattinoni, et al.
Cancer Cell|June 10, 2020
Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive ImmunotherapiesDevikala Gurusamy, Amanda N Henning, Tori N Yamamoto, et al.
Pageof 26

Showing results (191-200 of 260) with videos related to

Sort By:
Pageof 26
Immunity|April 23, 2013
MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancerJan C Dudda, Bruno Salaun, Yun Ji, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 19, 2019
Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With GlioblastomaStephanie L Goff, Richard A Morgan, James C Yang, et al.
Cancer Research|July 5, 2002
Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsivenessEna Wang, Lance D Miller, Galen A Ohnmacht, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 25, 2007
T-cell receptor gene therapy of established tumors in a murine melanoma modelJohn D Abad, Claudia Wrzensinski, Willem Overwijk, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunityChristian S Hinrichs, Zachary A Borman, Lydie Cassard, et al.
BMC Cancer|October 21, 2011
Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68Maria Libera Ascierto, Andrea Worschech, Zhiya Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2011
Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapySteven A Rosenberg, James C Yang, Richard M Sherry, et al.
Nature Reviews. Immunology|October 2, 2019
Defining 'T cell exhaustion'Christian U Blank, W Nicholas Haining, Werner Held, et al.
Blood|October 26, 2010
Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapyChristian S Hinrichs, Zachary A Borman, Luca Gattinoni, et al.
Cancer Cell|June 10, 2020
Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive ImmunotherapiesDevikala Gurusamy, Amanda N Henning, Tori N Yamamoto, et al.
Pageof 26